• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性肺栓塞全因死亡与肺栓塞相关死亡的危险因素差异:来自COMMAND VTE注册研究-2的见解

Differences in risk factors between all-cause and pulmonary embolism-related death in acute pulmonary embolism: insights from the COMMAND VTE registry-2.

作者信息

Kobayashi Soichiro, Ogihara Yoshito, Yamashita Yugo, Morimoto Takeshi, Chatani Ryuki, Kaneda Kazuhisa, Nishimoto Yuji, Ikeda Nobutaka, Kobayashi Yohei, Ikeda Satoshi, Kim Kitae, Inoko Moriaki, Takase Toru, Tsuji Shuhei, Oi Maki, Takada Takuma, Otsui Kazunori, Sakamoto Jiro, Inoue Takeshi, Usami Shunsuke, Chen Po-Min, Togi Kiyonori, Koitabashi Norimichi, Hiramori Seiichi, Doi Kosuke, Mabuchi Hiroshi, Tsuyuki Yoshiaki, Murata Koichiro, Takabayashi Kensuke, Nakai Hisato, Sueta Daisuke, Shioyama Wataru, Dohke Tomohiro, Sato Toru, Nishikawa Ryusuke, Kimura Takeshi, Dohi Kaoru

机构信息

Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan.

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

出版信息

Res Pract Thromb Haemost. 2025 Jul 3;9(5):102965. doi: 10.1016/j.rpth.2025.102965. eCollection 2025 Jul.

DOI:10.1016/j.rpth.2025.102965
PMID:40791607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12336812/
Abstract

BACKGROUND

Accurate risk prediction of early mortality, particularly pulmonary embolism (PE)-related death, in patients with acute PE has become more important for selecting optimal management strategies.

OBJECTIVES

To evaluate the cumulative 30-day incidence of and risk factors for all-cause and PE-related death within 30 days.

METHODS

In the COMMAND VTE Registry-2, which enrolled symptomatic patients with venous thromboembolism at 31 centers in Japan, we analyzed 2035 patients with acute PE.

RESULTS

The cumulative 30-day incidence of all-cause and PE-related death was 6.4% and 3.4%, respectively. Independent risk factors for all-cause and PE-related death were age >80 years (hazard ratio [HR], 2.43; 95% CI, 1.45-4.08; < .001), hypoxemia (HR, 3.36; 95% CI, 1.07-10.5; = .04), tachycardia (HR, 3.78; 95% CI, 2.20-6.50; < .001), hypotension (HR, 5.43; 95% CI, 3.17-9.29; < .001), an abnormal leukocyte count (HR, 1.78; 95% CI, 1.08-2.93; = .02), and the absence of proximal deep vein thrombosis (HR, 2.58; 95% CI, 1.51-4.39; < .001). Active cancer (HR, 2.59; 95% CI, 1.75-3.82; < .001) and male sex (HR, 1.56; 95% CI, 1.07-2.28; = .02) were independent risk factors for all-cause death, but not PE-related death. Chronic heart or lung disease (HR, 1.72; 95% CI, 1.02-2.90; = .04) and right ventricular dysfunction (HR, 2.61; 95% CI, 1.02-6.70; = .046) were independent risk factors for PE-related death, but not all-cause death.

CONCLUSION

We identified several independent risk factors for PE-related death within 30 days, which differed from those of all-cause death. Risk factors specifically for PE-related death may be useful in decision-making for optimal treatment strategies for acute PE.

摘要

背景

准确预测急性肺栓塞(PE)患者的早期死亡率,尤其是与PE相关的死亡,对于选择最佳治疗策略变得更加重要。

目的

评估30天内全因死亡和PE相关死亡的累积发生率及危险因素。

方法

在COMMAND VTE注册研究-2中,该研究纳入了日本31个中心有症状的静脉血栓栓塞患者,我们分析了2035例急性PE患者。

结果

全因死亡和PE相关死亡的30天累积发生率分别为6.4%和3.4%。全因死亡和PE相关死亡的独立危险因素为年龄>80岁(风险比[HR],2.43;95%置信区间[CI],1.45-4.08;P<0.001)、低氧血症(HR,3.36;95%CI,1.07-10.5;P = 0.04)、心动过速(HR,3.78;95%CI,2.20-6.50;P<0.001)、低血压(HR,5.43;95%CI,3.17-9.29;P<0.001)、白细胞计数异常(HR,1.78;95%CI,1.08-2.93;P = 0.02)以及无近端深静脉血栓形成(HR,2.58;95%CI,1.51-4.39;P<0.001)。活动性癌症(HR,2.59;95%CI,1.75-3.82;P<0.001)和男性(HR,1.56;95%CI,1.07-2.28;P = 0.02)是全因死亡的独立危险因素,但不是PE相关死亡的危险因素。慢性心肺疾病(HR,1.72;95%CI,1.02-2.90;P = 0.04)和右心室功能障碍(HR,2.61;95%CI,1.02-6.70;P = 0.046)是PE相关死亡的独立危险因素,但不是全因死亡的危险因素。

结论

我们确定了30天内与PE相关死亡的几个独立危险因素,这些因素与全因死亡的危险因素不同。专门针对PE相关死亡的危险因素可能有助于为急性PE的最佳治疗策略决策提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30d/12336812/08f199969df6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30d/12336812/f8a3614d6665/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30d/12336812/08f199969df6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30d/12336812/f8a3614d6665/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c30d/12336812/08f199969df6/gr2.jpg

相似文献

1
Differences in risk factors between all-cause and pulmonary embolism-related death in acute pulmonary embolism: insights from the COMMAND VTE registry-2.急性肺栓塞全因死亡与肺栓塞相关死亡的危险因素差异:来自COMMAND VTE注册研究-2的见解
Res Pract Thromb Haemost. 2025 Jul 3;9(5):102965. doi: 10.1016/j.rpth.2025.102965. eCollection 2025 Jul.
2
Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism.性别作为急性症状性肺栓塞成年患者死亡率的一个预后因素。
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD013835. doi: 10.1002/14651858.CD013835.pub2.
3
Are Patients With Morbid Obesity at Increased Risk of Pulmonary Embolism or Proximal Deep Vein Thrombosis After Lower Limb Arthroplasty? A Large-database Study.肥胖症患者下肢关节置换术后发生肺栓塞或近端下肢深静脉血栓的风险是否增加?一项大数据库研究。
Clin Orthop Relat Res. 2024 Jan 1;482(1):115-124. doi: 10.1097/CORR.0000000000002742. Epub 2023 Jul 4.
4
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism.口服直接凝血酶抑制剂或口服因子 Xa 抑制剂与传统抗凝剂治疗肺栓塞的比较。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD010957. doi: 10.1002/14651858.CD010957.pub3.
5
Prophylactic anticoagulants for non-hospitalised people with COVID-19.COVID-19 非住院患者的预防性抗凝治疗。
Cochrane Database Syst Rev. 2023 Aug 16;8(8):CD015102. doi: 10.1002/14651858.CD015102.pub2.
6
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.口服直接凝血酶抑制剂或口服因子 Xa 抑制剂与传统抗凝剂治疗深静脉血栓形成的比较。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD010956. doi: 10.1002/14651858.CD010956.pub3.
7
Standard- versus extended-duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients.急性病内科患者原发性静脉血栓栓塞症预防中标准疗程与延长疗程抗凝治疗的比较
Cochrane Database Syst Rev. 2024 Dec 4;12(12):CD014541. doi: 10.1002/14651858.CD014541.pub2.
8
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.药物干预预防接受减重手术人群的静脉血栓栓塞症。
Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2.
9
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.皮下注射普通肝素用于静脉血栓栓塞症的初始治疗。
Cochrane Database Syst Rev. 2017 Feb 14;2(2):CD006771. doi: 10.1002/14651858.CD006771.pub3.
10
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.对无诱因静脉血栓栓塞症(VTE)患者进行癌症检测对癌症及VTE相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3.

本文引用的文献

1
Predicting Short-Term Mortality in Patients With Acute Pulmonary Embolism With Deep Learning.利用深度学习预测急性肺栓塞患者的短期死亡率
Circ J. 2025 Apr 25;89(5):602-611. doi: 10.1253/circj.CJ-24-0630. Epub 2024 Nov 30.
2
Association Between White Blood Cell Counts at Diagnosis and Clinical Outcomes in Venous Thromboembolism - From the COMMAND VTE Registry-2.静脉血栓栓塞症诊断时白细胞计数与临床结局的关联——来自COMMAND VTE注册研究-2
Circ J. 2025 Apr 25;89(5):592-601. doi: 10.1253/circj.CJ-24-0581. Epub 2024 Oct 22.
3
Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral Anticoagulants.
直接口服抗凝剂时代基于简化的肺栓塞严重程度指数评分对肺栓塞患者进行家庭治疗选择和低危患者识别。
J Am Heart Assoc. 2024 Oct;13(19):e034953. doi: 10.1161/JAHA.124.034953. Epub 2024 Sep 30.
4
Prognostic value of pulmonary artery diameter/aorta diameter ratio in patients with acute pulmonary embolism.肺动脉直径/主动脉直径比值对急性肺栓塞患者的预后价值。
Herz. 2024 Dec;49(6):464-471. doi: 10.1007/s00059-024-05251-4. Epub 2024 Jun 4.
5
Evaluation of Naples prognostic score to predict long-term mortality in patients with pulmonary embolism.评估那不勒斯预后评分对预测肺栓塞患者长期死亡率的价值。
Biomark Med. 2024;18(6):253-263. doi: 10.2217/bmm-2023-0741. Epub 2024 Mar 15.
6
Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants.直接口服抗凝剂时代静脉血栓栓塞症患者的抗凝策略与长期复发。
Eur J Intern Med. 2023 Dec;118:59-72. doi: 10.1016/j.ejim.2023.08.007. Epub 2023 Aug 11.
7
The Role of Artificial Intelligence in Coronary Artery Disease and Atrial Fibrillation.人工智能在冠状动脉疾病和心房颤动中的作用。
Balkan Med J. 2023 May 8;40(3):151-152. doi: 10.4274/balkanmedj.galenos.2023.06042023. Epub 2023 Apr 7.
8
Causes of long-term mortality in patients with venous thromboembolism in the real world: From the COMMAND VTE registry.现实世界中静脉血栓栓塞症患者的长期死亡原因:来自COMMAND VTE注册研究
Thromb Res. 2022 Nov;219:30-39. doi: 10.1016/j.thromres.2022.09.002. Epub 2022 Sep 7.
9
Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.执行摘要:静脉血栓栓塞症的抗血栓治疗:CHEST 指南和专家小组报告的第二次更新。
Chest. 2021 Dec;160(6):2247-2259. doi: 10.1016/j.chest.2021.07.056. Epub 2021 Aug 2.
10
Sex differences in presentation, management, and outcomes among patients hospitalized with acute pulmonary embolism.急性肺栓塞住院患者的临床表现、治疗和结局的性别差异。
Vasc Med. 2020 Dec;25(6):541-548. doi: 10.1177/1358863X20964577. Epub 2020 Nov 17.